The immunobiology of cholangiocytes

Immunology and Cell Biology

Volumn 86, Issue 6, 2008, Pages 497-505

  Chen, Xian Ming ^a   O'Hara, Steven P ^b   LaRusso, Nicholas F ^b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Biliary epithelium; Immunity; MicroRNAs; Toll like receptors

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN A; MITOGEN ACTIVATED PROTEIN KINASE; MYXOVIRUS RESISTANCE PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIGEN PRESENTING CELL; CHOLANGIOCYTE; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOBIOLOGY; LIVER CELL; REVIEW;

ANIMALS; BILE DUCTS; EPITHELIAL CELLS; HUMANS;

EID: 49649123486     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.37     Document Type: Review

References (119)

1. Adams DH, Afford SC. The role of cholangiocytes in the development of chronic inflammatory liver disease. Front Biosci 2002; 7: e276-e285.
2. Sheen-Chen S, Chen W, Eng H, Sheen C, Chou F, Cheng Y et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 2000; 28: 298-301.
3. Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 2000; 33: 9-18.
4. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1998; 29: 409-416.
5. Harada K, Ozaki S, Kono N, Tsuneyama K, Katayanagi K, Hiramatsu K et al. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J Pathol 2001; 193: 218-223.
6. Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A et al. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 2004; 40: 925-932.
7. Vaishnavi C, Kochhar R, Kaur S, Singh G. Estimation of endotoxin in infected bile from patients with biliary diseases. Trop Gastroenterol 2006; 27: 22-25.
8. Yanaga K, Yoshizumi T, Uchiyama H, Okano S, Takenaka K, Sugimachi K. Detection of hepatitis C virus RNA in bile. Am J Gastroenterol 1997; 92: 1927-1928.
9. Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006; 26: 467-476.
10. Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 2005; 175: 7447-7456.
11. Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res 2007; 37: S430-S437.
12. Fava G, Glaser S, Francis H, Alpini G. The immunophysiology of biliary epithelium. Semin Liver Dis 2005; 25: 251-264.
13. Selmi C, Mackay IR, Gershwin ME. The immunological milieu of the liver. Semin Liver Dis 2007; 27: 129-139.
14. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer J, Poustka A et al. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 2004; 24: 29-37.
15. Sheth P, Delos Santos N, Seth A, LaRusso NF, Rao RK. Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2007; 293: G308-G318.
16. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-835.
17. Dong H, Chen XM. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol Immunol 2006; 3: 179-187.
18. Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat Immunol 2005; 6: 1198-1205.
19. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
20. Viala J, Sansonetti P, Philpott DJ. Nods and 'intracellular' innate immunity. C R Biol 2004; 327: 551-555.
21. Jo YJ, Choi HS, No NY, Lee OY, Han DS, Hahm JS et al. Expression of Toll-like receptor in the biliary epithelial cell lines and human gallbladder tissues. Gastroenterology 2004; 126: A171.
22. Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 2003; 83: 1657-1667.
23. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003; 170: 1406-1415.
24. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004; 4: 953-964.
25. Shibolet O, Podolsky DK. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1469-G1473.
26. Miyaso H, Morimoto Y, Ozaki M, Haga S, Shinoura S, Choda Y et al. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol 2005; 20: 1859-1866.
27. Harada K, Isse K, Nakanuma Y. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 2006; 59: 184-190.
28. Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int 2006; 26: 935-942.
29. Huang YH, Chou MH, Du YY, Huang CC, Wu CL, Chen CL et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest 2007; 87: 66-74.
30. Karrar A, Broomé U, Södergren T, Jaksch M, Bergquist A, Björnstedt M et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007; 132: 1504-1514.
31. Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Zen Y et al. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest 2007; 87: 559-571.
32. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007; 282: 28929-28938.
33. Broomé U, Scheynius A, Hultcrantz R. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 2005; 18: 298-303.
34. Sakisaka S, Koga H, Sasatomi K, Ohishi M, Kawaguchi T, Harada M et al. Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis. Liver 2000; 20: 78-87.
35. Körner T, Kropf J, Hackler R, Brenzel A, Gressner AM. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases. Hepatology 2003; 23: 423-428.
36. Nelson JB, O'Hara SP, Small AJ, Tietz PS, Choudhury AK, Pagano RE et al. Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains. Cell Microbiol 2006; 8: 1932-1945.
37. Rogers KA, Rogers AB, Leav BA, Sanchez A, Vannier E, Uematsu S et al. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun 2006; 74: 549-556.
38. Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003; 198: 1225-1235.
39. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 2007; 56: 2687-2697.
40. Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. Genetic analysis of innate immunity: identification and function of the TIR adapter proteins. Adv Exp Med Biol 2005; 560: 29-39.
41. Kobayashi K, Inohara N, Hernandez LD, Galán JE, Núñez G, Janeway CA et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194-199.
42. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Núñez G et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 2008; 27: 373-383.
43. Hayden MS, Ghosh S. Chared principles in NF-kB signaling. Cell 2008; 132: 344-362.
44. Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002; 10: 693-695.
45. Frendéus B, Wachtler C, Hedlund M, Fischer H, Samuelsson P, Svensson M et al. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 2001; 40: 37-51.
46. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74: 589-607.
47. Katsoulidis E, Li Y, Mears H, Platanias LC. The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 2005; 25: 749-756.
48. Pimienta G, Pascual J. Canonical and alternative MAPK signaling. Cell Cycle 2007; 6: 2628-2632.
49. Lang R, Hammer M, Mages J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006; 177: 7497-7504.
50. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol 2005; 7: 1387-1397.
51. Park J, Gores GJ, Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology 1999; 29: 1037-1043.
52. Jafri M, Donnelly B, McNeal M, Ward R, Tiao G. MAPK signaling contributes to rotaviral-induced cholangiocyte injury and viral replication. Surgery 2007; 142: 192-201.
53. Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 1997; 109: 372-382.
54. Fabris L, Strazzabosco M, Crosby HA, Ballardini G, Hubscher SG, Kelly DA et al. Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol 2000; 156: 1599-1612.
55. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998; 27: 472-480.
56. Lazaridis KN, Strazzabosco M, LaRusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 2004; 127: 1565-1577.
57. Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and Tlymphocyte adhesion. Hepatology 1994; 19: 426-431.
58. Scholz M, Cinatl J, Blaheta RA, Kornhuber B, Markus BH, Doerr HW. Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection. Tissue Antigens 1997; 49: 640-643.
59. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 1998; 29: 550-558.
60. Bloom S, Fleming K, Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 1995; 36: 604-609.
61. Sheen-Chen SM, Eng HL, Cheng YF, Chou FF, Chen WJ. Circulating intercellular adhesion molecule-1 (ICAM-1) in patients with hepatolithiasis. Dig Dis Sci 1996; 41: 1682-1686.
62. Hsu HY, Chang MH, Ni YH, Huang SF. Cytomegalovirus infection and proinflammatory cytokine activation modulate the surface immune determinant expression and immunogenicity of cultured murine extrahepatic bile duct epithelial cells. Clin Exp Immunol 2001; 126: 84-91.
63. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 1997; 112: 968-977.
64. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of proinflammatory cytokines. Gut 1993; 34: 1245-1249.
65. Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991; 13: 239-246.
66. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003; 198: 39-50.
67. Chen XM, Levine SA, Tietz P, Krueger E, McNiven MA, Jefferson DM et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998; 28: 906-913.
68. Adams DH, Afford SC. The role of cholangiocytes in the development of chronic inflammatory liver disease. Front Biosci 2002; 7: e276-e285.
69. O'Hara SP, Small AJ, Nelson JB, Badley AD, Chen XM, Gores GJ et al. The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun 2007; 75: 684-696.
70. Chen XM, Gores GJ, Paya CV, LaRusso NF. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol 1999; 277: G599-G608.
71. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr Pharm Des 2007; 13: 3131-3139.
72. Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T et al. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 2002; 169: 2516-2523.
73. Menendez A, Brett Finlay B. Defensins in the immunology of bacterial infections. Curr Opin Immunol 2007; 19: 385-391.
74. Haller O, Kochs G. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002; 3: 710-717.
75. Leifeld L, Ramakers J, Schneiders AM, Dumoulin FL, Sterneck M, Müller A et al. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J Pathol 2001; 194: 478-483.
76. Huang YH, Chou MH, Du YY, Huang CC, Wu CL, Chen CL et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest 2007; 87: 66-74.
77. Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C. Expression of the interferon-induced Mx proteins in biliary atresia. J Pediatr Surg 2006; 41: 1139-1143.
78. Harada K, Sato Y, Itatsu K, Isse K, Ikeda H, Yasoshima M et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 2007; 46: 1146-1154.
79. Sakisaka S, Gondo K, Yoshitake M, Harada M, Sata M, Kobayashi K et al. Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs. Hepatology 1996; 24: 398-406.
80. Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW. Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 1996; 39: 136-140.
81. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 1994; 12: 63-84.
82. Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007; 132: 415-431.
83. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
84. Shaykhiev R, Behr J, Bals R. Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival. PLoS ONE 2008; 3: e1393.
85. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002; 8: 1089-1097.
86. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001; 194: 189-203.
87. Nozaki I, Lunz III JG, Specht S, Park JI, Giraud AS, Murase N et al. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 2004; 165: 1907-1920.
88. Hertel SC, Chwieralski CE, Hinz M, Rio MC, Tomasetto C, Hoffmann W. Profiling trefoil factor family (TFF) expression in the mouse: identification of an antisense TFF1-related transcript in the kidney and liver. Peptides 2004; 25: 755-762.
89. Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 2002; 40: 261-268.
90. Sasaki M, Ikeda H, Ohira S, Ishikawa A, Nakanuma Y. Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis. Peptides 2004; 25: 763-770.
91. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol Gastrointest Liver Physiol 1995; 269: G467-G475.
92. Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of TJs in the Caco-2 cell monolayer. J Biol Chem 2003; 278: 11916-11924.
93. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004; 127: 224-238.
94. Chen XM, Huang BQ, Splinter PL, Cao H, Zhu G, McNiven MA et al. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. Gastroenterology 2003; 125: 216-228.
95. Spirlì C, Fabris L, Duner E, Fiorotto R, Ballardini G, Roskams T et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology 2003; 124: 737-753.
96. Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci 2002; 7: d1899-d1914.
97. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G626-G634.
98. Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gudmundsson G et al. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 2003; 278: 53035-53044.
99. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526.
100. Wang AP, Migita K, Ito M, Takii Y, Daikoku M, Yokoyama T et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 2005; 25: 85-91.
101. Karrar A, Broomé U, Södergren T, Jaksch M, Bergquist A, Björnstedt M et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007; 132: 1504-1514.
102. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
103. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
104. Voinnet O. Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 2005; 6: 206-220.
105. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308: 557-560.
106. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
107. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-130.
108. Gantier MP, Sadler AJ, Williams BR. Fine-tuning of the innate immune response by microRNAs. Immunol Cell Biol 2007; 85: 458-462.
109. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007; 26: 133-137.
110. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113-2129.
111. Lang T, Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 2007; 85: 425-434.
112. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000; 18: 143-164.
113. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999; 98: 597-608.
114. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677-687.
115. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006; 7: 148-155.
116. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454-465.
117. Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S et al. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 2007; 132: 384-396.
118. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609.
119. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486.